A Phase 1, First In Human Study Of Ds-1055A In Subjects With Relapsed Or Refractory Locally Advanced Or Metastatic Solid Tumors
Posted Date: Apr 26, 2024
- Investigator: Trisha Wise-Draper
- Type of Study: Drug
The purpose of this study is to assess the safety and tolerability of DS-1055a in participants with relapsed or refractory locally advanced or metastatic solid tumors for which no standard treatment is available.
Criteria:
Null
Keywords:
Solid Tumors
For More Information:
Kayla Webb
NULL
cancer@uchealth.com